VERTEX PHARMAC. DL-,01/ US92532F1003 /
2024-05-14 9:35:35 PM | Chg. -3.000 | Volume | Bid10:00:02 PM | Ask10:00:02 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
395.200EUR | -0.75% | 144 Turnover: 56,740.550 |
394.050Bid Size: 25 | 397.900Ask Size: 25 | 102.22 bill.EUR | - | - |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 14.05 USD | 8.33% |
EPS Diluted: | 13.89 USD | 8.35% |
Revenues per Share: | 38.21 USD | 9.99% |
Book Value per Share: | 68.06 USD | 25.77% |
Cash Flow per Share: | 13.69 USD | -14.75% |
Dividend per Share: | - USD | - |
Total | in mill. | |
Revenues: | 9,869.20 USD | 10.51% |
Net Income: | 3,619.60 USD | 8.96% |
Operating Cash Flow: | 3,537.30 USD | - |
Cash and Cash Equivalents: | 10,369.10 USD | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 30.50 | 28.96 |
P/S Ratio: | 11.22 | 10.65 |
P/BV ratio: | 6.30 | 5.98 |
P/CF Ratio: | 31.30 | 29.71 |
PEG: | 3.66 | 3.48 |
Earnings Yield: | 3.28% | 3.45% |
Dividend Yield: | - | - |
Market Capitalization | ||
Market Capitalization: | 102.22 bill. EUR | 95.19 bill. EUR |
Free Float Market Cap.: | - EUR | - EUR |
Market Cap. / Employee: | - EUR | - EUR |
Shares Outstanding: | 258.31 mill. |
Profitability
Gross Profit Margin: | 87.21% |
EBIT Margin: | 38.83% |
Net Profit Margin: | 36.68% |
Return on Equity: | 20.59% |
Return on Assets: | 15.92% |
Financial Strength
Liquidity I / Cash Ratio: | 292.30% |
Liquidity II / Quick Ratio: | 336.37% |
Liquidity III / Current Ratio: | 398.72% |
Debt / Equity Ratio: | 29.29% |
Dynam. Debt / Equity Ratio: | 145.59% |
Efficiency
Employees: | - |
Personal Expenses / Employee: | - USD |
Revenues / Employee: | - USD |
Net Income / Employee: | - USD |
Total Assets / Employee: | - USD |
* Fiscal Year End: | 2023-12-31 |
Accounting Standard: | US GAAP |
Currency: | USD |